Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead

As great of an investment as Eli Lilly (LLY -0.86%) is during the age of Zepbound, its newest and hottest weight-loss drug, there are many other magnificent opportunities out there right now, and it'd be a disservice to your portfolio to ignore them entirely.Take Iovance Biotherapeutics (IOVA -2.11%), for example. Its shares are up by 110% over the last 12 months, and if you can adopt a long-term mindset, the party could be just getting started. Here's why it's worth thinking about buying.This stock has cat ...